Диссертация-Козырев-И.А.. Диссертация на соискание ученой степени кандидата медицинских наук Научные руководители доктор медицинских наук профессор Гордеев М. Л., кандидат биологических наук
Скачать 3.84 Mb.
|
147. Yester, J. Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration / J.W. Yester, B. Kühn // Current cardiology reports. —2017.— Vol.19, №2.— P.13. 148. Polizzotti, B. Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window / B.D. Polizzotti, B. Ganapathy, S. Walsh, [et al.] // Science translational medicine. —2015.— Vol.7, №281 (281ra45).— P.1-13. 149. Porrello, E. Transient regenerative potential of the neonatal mouse heart / E.R. Porrello, A.I. Mahmoud, E. Simpson, [et al.] // Science (New York, NY). —2011.— Vol.331, №6020.— P.1078-80. 150. Notari, M. The local microenvironment limits the regenerative potential of the mouse neonatal heart / M. Notari, A. Ventura-Rubio, S.J. Bedford-Guaus, [et al.] // Science Advances. —2018.— Vol.4, №5 (eaao5553).— P.1-13. 151. Mishra, R. Characterization and functionality of cardiac progenitor cells in congenital heart patients / R. Mishra, K. Vijayan, E.J. Colletti, [et al.] // Circulation. —2011.— Vol.123, №4.— P.364-73. 152. Haubner, B. Functional recovery of a human neonatal heart after severe myocardial infarction / B.J. Haubner, J. Schneider, U. Schweigmann, [et al.] // Circulation research. —2016.— Vol.118, №2.— P.216-21. 153. Ye, L. Cardiomyocytes in Young Infants With Congenital Heart Disease: a Three-Month Window of Proliferation / L. Ye, L. Qiu, H. Zhang, [et al.] // Scientific reports. —2016.—Vol.6, №23188.-P.1-8. 120 154. Худяков, А. Сравнение эффективности методов получения функционально активных кардиомиоцитов человека / А. Худяков, Д. Курапеев, А. Костарева, [и др.] // Гены и клетки. — 2013.—Vol .8, №2.— с.47-55. 155. Нарциссова, Г. Оценка легочной регургитации методом допплер-эхокардиографии у пациентов после радикальной коррекции тетрады Фалло / Г.П. Нарциссова, Д.С. Прохорова, Н.В. Матвеева, [и др.] // Патология кровообращения и кардиохирургия. — 2012.—Vol .№2.— с.15-19. 156. E. Bacha. Valve-Sparing or Valve Reconstruction Options in Tetralogy of Fallot Surgery / E. Bacha // Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual. —2017.— Vol.20, —P.79-83. 157. Piazza, L. Timing of pulmonary valve replacement after tetralogy of Fallot repair / L. Piazza, M. Chessa, A. Giamberti, [et al.] // Expert review of cardiovascular therapy. —2012.— Vol.10, №7.— P.917- 23. 158. Е. Пшеничная. Внезапная сердечная смерть у детей. Часть 1 / Е. Пшеничная // Здоровье ребенка. —2013.—Vol.1, №44.— c.135- 39. 159. Mouws, E. Tetralogy of Fallot in the Current Era / E. Mouws, N.M.S. de Groot, P.C. van de Woestijne, [et al.] // Seminars in thoracic and cardiovascular surgery. —2018.—Vol. 31, №3. —P.496-501. 160. Бокерия, Л. Тетрада Фалло у младенцев: возможно ли уменьшить процент трансаннулярной пластики при ранней радикальной коррекции / Л. Бокерия, А. Ким, О. Махачев, [и др.] // Бюллетень НЦССХ им АН Бакулева РАМН Сердечно-сосудистые заболевания. —2004.—Vol.5, №5.— с.25-28. 161. Kim, D. Optimal Pulmonary Valve Annulus Diameter for Annulus Preservation in Tetralogy of Fallot May Be Far Smaller Than 121 Normal Annulus Size / D.H. Kim, J.H. Lee, E.S. Choi, [et al.] // Seminars in thoracic and cardiovascular surgery. —2018.—Vol.31, №2. —P.253- 63. 162. Singh, S. Pulmonary valve preservation in Tetralogy of Fallot with a mildly hypoplastic annulus-should we do it? / S. Singh, H. Pratap, S. Agarwal, [et al.] // Indian Journal of Thoracic and Cardiovascular Surgery. —2011.— Vol.27, №2.— P.76-81. 163. Liu, M. Risk-adjusted prolonged length of stay as an alternative outcome measure for pediatric congenital cardiac surgery / M. Liu, C.M. Druschel, E.L. Hannan // The Annals of thoracic surgery. — 2014.— Vol.97, №6.— P.2154-9. 164. Limperopoulos, C. Predictors of developmental disabilities after open heart surgery in young children with congenital heart defects / C. Limperopoulos, A. Majnemer, M.I. Shevell, [et al.] // The Journal of pediatrics. —2002.—Vol.1 41, №1.— P.51-8. 165. Newburger, J. Length of stay after infant heart surgery is related to cognitive outcome at age 8 years / J.W. Newburger, D. Wypij, D.C. Bellinger, [et al.] // The Journal of pediatrics. —2003.—Vol.143, №1.— P.67-73. 166. Emani, S. Cell-Based Therapy With Cardiosphere-Derived Cardiocytes: A New Hope for Pediatric Patients With Single Ventricle Congenital Heart Disease? / S.M. Emani, P.J. Del Nido // Circulation research. —2018.— Vol.122, №7.— P.916-7. 167. Sano, T. Impact of Cardiac Progenitor Cells on Heart Failure and Survival in Single Ventricle Congenital Heart Disease / T. Sano, D. Ousaka, T. Goto, [et al.] // Circulation research. —2018.—Vol.122, №7.— P.994-1005. 168. Ishigami, S. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP 122 prospective phase 1 controlled trial / S. Ishigami, S. Ohtsuki, S. Tarui, [et al.] // Circulation research. —2015.— Vol.116, №4.— P.653-64. 169. Tarui, S. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial / S. Tarui, S. Ishigami, D. Ousaka, [et al.] // The Journal of thoracic and cardiovascular surgery. — 2015.— Vol.150, №5.— P.1198-208. 170. Ishigami, S. Intracoronary cardiac progenitor cells in single ventricle physiology: the PERSEUS (Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease) randomized phase 2 trial / S. Ishigami, S. Ohtsuki, T. Eitoku, [et al.] // Circulation research. —2017.— Vol.120, №7.— P.1162-73. 171. Kaushal, S. Study design and rationale for elpis: A phase i/iib randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. S. Kaushal, B. Wehman, N. Pietris, [et al.] // American heart journal. —2017. —Vol.192, —P.48-56. 172. Ozlek, B. Rationale, design, and methodology of the apollon trial: A comprehensive, observational registry of heart failure with midrange and preserved ejection fraction. B. Ozlek, E. Ozlek, O. Celik, [et al.] // Anatolian journal of cardiology. —2018. —Vol.19. —P.311-18. 173. Boni, A. Notch1 regulates the fate of cardiac progenitor cells / A. Boni, K. Urbanek, A. Nascimbene, [et al.] // Proceedings of the National Academy of Sciences. —2008.— Vol.105, №40.— P.15529-34. 174. Secco, I. Notch pathway activation enhances cardiosphere in vitro expansion / I. Secco, L. Barile, C. Torrini, [et al.] // Journal of cellular and molecular medicine. —2018.— Vol.22, №11.— P.5583-95. 123 175. Chen, L. The role of notch 1 activation in cardiosphere derived cell differentiation / L. Chen, M. Ashraf, Y. Wang, [et al.] // Stem cells and development. —2012.— Vol.21, №12.— P.2122-9. 176. Urbanek, K. Inhibition of Notch1-Dependent Cardiomyogenesis Leads to a Dilated Myopathy in the Neonatal HeartNovelty and Significance / K. Urbanek, M.C. Cabral-da-Silva, N. Ide-Iwata, [et al.] // Circulation research. —2010.— Vol.107, №3.— P.429-41. 177. Ye, L. Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects / L. Ye, M. Yin, Y. Xia, [et al.] // PLoS One. —2015.— Vol.10, №10 (e0139712).— P.1-11. 178. D'Uva, G. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation / G. D'Uva, A. Aharonov, M. Lauriola, [et al.] // Nature cell biology. —2015.— Vol.17, №5.— P.627-38. 179. Flurkey, K. Pitfalls of animal model systems in ageing research / K. Flurkey, J.M. Currer // Best practice & research Clinical endocrinology & metabolism. —2004.— Vol.18, №3.— P.407-21. 180. Postma, A. Genetics of congenital heart disease: the contribution of the noncoding regulatory genome / A.V. Postma, C.R. Bezzina, V.M. Christoffels // Journal of human genetics. —2016.— Vol.61, №1.— P.13-9. |